Sort
78,016 grants matching “breast cancer”
Nuclear Structure and Gene Expression
$669,529Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · CA
Imaging Modulation of Immune Phenotype
$669,526Katherine W Ferrara · Stanford University · R01 · FY2021 · CA
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
$669,504Lorenzo Cohen · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$669,492Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Data Processing, Analysis and Modeling Unit
$669,457Jeremy Goecks · Oregon Health & Science University · U2C · FY2022 · CA
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring
$669,448Daniel B Vigneron · University Of California, San Francisco · R01 · FY2021 · CA
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
$669,442Lydia B Zablotska · University Of California, San Francisco · R01 · FY2018 · CA
Structure and function of RAD51 paralog tumor suppressor complexes in genome maintenance
$669,325Shaun Olsen · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Radiomics and Pathomics to predict upstaging of DCIS
$669,313Bethany Lynn Niell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Radiomics and Pathomics to predict upstaging of DCIS
$669,313Bethany Lynn Niell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Nano-Engineered Lab-on-a-Chip for Assessing HuR-Regulated Exosomes for Cancer Monitoring and Targeted Therapy
$669,271Liang Xu · University Of Kansas Lawrence · R01 · FY2021 · CA
Efficacy of a Multi-Antigen Vaccine in the Prevention of Methylnitrosourea
$669,243University Of Alabama At Birmingham · N01 · FY2012 · CA
Improving Cancer Outcomes for African-Americans
$669,177Patrick D Maguire · New Hanover Regional Medical Center · U56 · FY2006 · CA
Sanford Community Cancer Consortium
$669,174Miroslaw Mazurczak · Sanford Research/Usd · U10 · FY2013 · CA
Vault-CCL21 Nanocapsule for Lung Cancer
$669,156Indresh K Srivastava · Protein Sciences Corporation · U44 · FY2014 · CA
Deciphering the Mechanism of Lymphovascular Space Invasion Using a Lymphovascularized Bioengineering Breast Stromal Platform
$669,122Marissa Nichole Rylander · University Of Texas At Austin · R01 · FY2024 · CA
Addressing challenges in colorectal cancer risk prediction
$669,119Kerrie P Nelson · Boston University Medical Campus · R01 · FY2025 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$669,027John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Impact of enhancements to smartphone-based continuing care for alcohol dependence
$668,933James R McKay · University Of Pennsylvania · R01 · FY2014 · AA
Impact of exercise on ovarian cancer prognosis
$668,926Melinda L Irwin · Yale University · R01 · FY2010 · CA
Genomic and Morphologic Predictor of High-Risk DCIS
$668,899Robert B West · Stanford University · R01 · FY2019 · CA
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
$668,888Susan K Lutgendorf · University Of Iowa · R01 · FY2016 · CA
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$668,834Lorna Rodriguez-Rodriguez · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Genomic Biology of the Tandem Duplicator Phenotype in Mouse and Human Cancers
$668,795Edison Tak-Bun Liu · Jackson Laboratory · R01 · FY2024 · CA
Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes
$668,794Aniket A Kawatkar · Kaiser Foundation Research Institute · R01 · FY2023 · HL